Pharmaceutical companies are among the most targeted organisations for nation-state espionage — their clinical trial data, drug formulations, and manufacturing processes represent years of R&D investment valued in the billions — while simultaneously operating under FDA 21 CFR Part 11, GxP data integrity requirements, and DSCSA supply-chain security mandates. Zero Trust architecture protects pharma R&D and manufacturing environments by enforcing identity-verified access to LIMS, ERP, and manufacturing execution systems, while providing the audit trails required by GxP and FDA inspection programmes.
Pharma